Bionet (1784) — Financial Flexibility Index
Bionet (1784) has a Financial Flexibility Index of 0.08x as of December 2025. Free cash flow of NT$66.48 Million (operating CF NT$28.46 Million minus capex NT$38.02 Million) represents 0% of total liabilities (NT$822.58 Million). Check Bionet PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bionet Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Bionet across 9 annual periods. See Bionet (1784) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bionet (2017–2025)
Year-by-year free cash flow to debt coverage for Bionet. For the full company profile including market capitalisation, see Bionet (1784) total market value.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | NT$280.22 Million | NT$148.04 Million | NT$822.58 Million | ▼ -7.5% |
| 2024 | 0.37x | NT$279.98 Million | NT$176.49 Million | NT$760.40 Million | ▲ +28.6% |
| 2023 | 0.29x | NT$179.38 Million | NT$153.09 Million | NT$626.47 Million | ▲ +15.4% |
| 2022 | 0.25x | NT$127.56 Million | NT$94.65 Million | NT$513.97 Million | ▲ +280.5% |
| 2021 | 0.07x | NT$30.54 Million | NT$13.88 Million | NT$468.19 Million | ▼ -74.0% |
| 2020 | 0.25x | NT$111.69 Million | NT$73.66 Million | NT$445.44 Million | ▲ +697.5% |
| 2019 | 0.03x | NT$14.27 Million | NT$2.67 Million | NT$453.87 Million | ▲ +282.0% |
| 2018 | 0.01x | NT$3.65 Million | NT$-12.97 Million | NT$443.09 Million | ▲ +124.9% |
| 2017 | -0.03x | NT$-14.96 Million | NT$-24.91 Million | NT$453.33 Million | — |